Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats

Ru Li, Ruotong Liu, Haoyu Xing, Yueming Yuan, Zheng Yuan, Zhiyong Xu, Qin Xu, Jianping Song, Xiaobo LiFrontiers in Pharmacology 2023 · DOI

This study provides a rigorous toxicological evaluation of Gancao Xiexin decoction (GCXXD), a classic Traditional Chinese Medicine (TCM) formula. While the decoction was found to be safe in acute high doses, 28-day repeated administration revealed a gender-specific sensitivity: high doses caused mild, reversible anemia in female rats, establishing a No-Observed-Adverse-Effect Level (NOAEL) of 3.83 g/kg.

What Problem Does This Paper Address?

Traditional Chinese Medicine has a history spanning thousands of years, yet many commonly used formulas lack the standardized toxicological data required by modern pharmacology. GCXXD—a mixture of six herbs including licorice, skullcap, and ginger—is widely prescribed for oral and gastrointestinal ulcers and Behcet disease.

One of its key ingredients, Pinellia ternata (Banxia), is known to be toxic in its raw form, potentially causing hepatotoxicity or gastrointestinal distress. The challenge lies in verifying whether the traditional preparation and combination of these herbs are truly safe for consumption under modern clinical standards. This paper seeks to establish a safety profile for GCXXD using Sprague-Dawley rats to determine safe dosage thresholds.

Methods

The researchers followed a standardized protocol to produce the GCXXD extract, ensuring quality control via High-Performance Liquid Chromatography (HPLC) to track active compounds like glycyrrhizin and baicalin. The study was split into two main phases:

  1. Acute Toxicity Study: Rats were given a massive dose of 30 g/kg (split into three doses in one day) and observed for 14 days to check for immediate mortality or clinical abnormalities.
  2. Subacute Toxicity Study: Rats received daily oral doses (0, 1.47, 3.83, or 10 g/kg) for 28 days, followed by a 14-day recovery period.

The team monitored a comprehensive suite of health indicators, including body weight, food consumption, hematology (blood counts), serum biochemistry (liver and kidney function), organ weights, and histopathology (microscopic tissue examination).

Datasets

The study utilized Specific Pathogen-Free (SPF) Sprague-Dawley rats (6–8 weeks old).

  • Acute study: 20 rats (10 male, 10 female).
  • Subacute study: 120 rats (60 male, 60 female).
  • Material: GCXXD extract (batch number 190516), standardized against the Chinese Pharmacopoeia (2015 version).

Key Insights and Ideas

  • The Gender Gap in Toxicity: The most striking finding was that only female rats showed adverse hematological effects at the highest dose. This highlights the importance of gender-disaggregated data in toxicology, as hormonal differences or variations in drug metabolism can lead to different safety outcomes.
  • Processing Neutralizes Toxicity: Despite containing Pinellia ternata, no signs of hepatotoxicity, nephrotoxicity, or cardiotoxicity were found. This suggests that the traditional "Paozhi" (processing) and the synergistic effects of the formula successfully mitigate the inherent toxicity of individual raw ingredients.
  • Reversibility: The mild anemia observed in high-dose females was not permanent. After a 14-day "washout" period without the drug, blood parameters returned to normal, suggesting the effect is transient and dose-dependent.

Key Results

  • Acute Safety: No mortality or clinical signs of toxicity were observed at 30 g/kg/day. The median lethal dose ($LD_{50}$) is likely much higher than 30 g/kg.
  • Hematological Changes: In the subacute study, female rats in the 10 g/kg group showed significantly decreased Red Blood Cell (RBC) counts, Hemoglobin (HGB), and Hematocrit (HCT).
  • Biochemistry & Histology: No significant treatment-related abnormalities were found in liver enzymes, kidney markers, or tissue morphology across all groups.
  • Safety Thresholds:
    • NOAEL (No-Observed-Adverse-Effect Level): 3.83 g/kg.
  • LOAEL (Lowest-Observed-Adverse-Effect Level): 10 g/kg.
  • Human Equivalence: The NOAEL of 3.83 g/kg is approximately 21 times the proposed human clinical dose, providing a substantial safety margin.

Limitations and Future Work

While this study provides a strong foundation, the authors acknowledge several limitations:

  • Duration: A 28-day study is considered "subacute." Chronic toxicity studies (6 months or longer) are necessary to ensure safety for long-term clinical use.
  • Mechanistic Mystery: The study identifies that female rats are more sensitive to anemia, but it does not explain why. Further research into the interaction between GCXXD and estrogen or specific metabolic pathways is needed.
  • Scope: The study did not evaluate reproductive toxicity or genotoxicity (potential damage to DNA), which are standard components of a full safety profile.

Summary updated

Abstract

Gancao Xiexin decoction (GCXXD), a well-known classic traditional Chinese medicine prescription, is used to treat various oral ulcers, Behcet disease, gastrointestinal ulcers, etc. However, there is very little information on its safety. This study aimed to investigate the acute and subacute oral toxicity of GCXXD in Sprague-Dawley rats. In the acute toxicity study, rats were orally administered 10 g/kg GCXXD three times a day. Clinical signs of abnormality and mortality were observed daily for 14 days. In the subacute toxicity study, rats were orally administered 0, 1.47, 3.83, or 10 g/kg GCXXD for 28 days. The rats' clinical signs, body weight, food consumption, hematological and biochemical parameters, bone marrow smear, organ index, and pathological morphology were analyzed. The acute toxicity study showed that GCXXD is safe in rats without any obvious toxicity <i>via</i> an oral dose of 30 g/kg/day (3 × 10 g/kg). After 28 days of administration, slightly decreased RBC, HGB, and HCT were observed in female rats at 10 g/kg, suggesting that repeated doses of high-dose GCXXD may cause mild anemia in female rats. The no-observed-adverse-effect level (NOAEL) and lowest-observed-adverse-effect level (LOAEL) of oral administration of GCXXD for 28 days in rats are considered to be 3.83 g/kg and 10 g/kg, respectively. Long-term toxicity studies are recommended to strengthen the findings.
BibTeX
@inproceedings{li2023acute,
  author = {Ru Li and Ruotong Liu and Haoyu Xing and Yueming Yuan and Zheng Yuan and Zhiyong Xu and Qin Xu and Jianping Song and Xiaobo Li},
  title = {{Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats}},
  booktitle = {Frontiers in Pharmacology},
  year = {2023},
  doi = {10.3389/fphar.2022.1078665},
}
Figure